logo
Cells are the smallest, most basic unit of life. Do they also hold memories?

Cells are the smallest, most basic unit of life. Do they also hold memories?

Globe and Mail4 days ago
Thomas Verny is a clinical psychiatrist, academic, award-winning author, public speaker, poet and podcaster. He is the author of eight books, including the global bestseller The Secret Life of the Unborn Child and 2021'sThe Embodied Mind: Understanding the Mysteries of Cellular Memory, Consciousness and Our Bodies.
Joshua Bongard, professor of computer science at the University of Vermont, believes that as humans and animals evolved and adapted to their surroundings, so did their tissues and cells. 'What we are is intelligent machines made of intelligent machines made of intelligent machines, all the way down,' he said, referring to cells. [1]
Cells are the smallest, basic unit of life responsible for all of life's processes. A typical human cell has a membrane filled with a jellylike fluid called the cytoplasm. The cytoplasm contains structures called organelles that perform functions similar to major organs. For example, the mitochondria are the lungs of the cell. The nucleus, another organelle, contains the genetic material as DNA. Another important organelle is the cytoskeleton which consists of a cellular scaffolding or skeleton within a cell's cytoplasm. It is made up of microtubules, assembled from the protein tubulin into tube-shaped networks. Some studies support the view that it is the microtubules within the cytoskeleton that store memories. [2]. In addition to 37 organelles, each human cell contains about 12,000 proteins that amount to 42 million protein molecules.
A human adult's body contains 50 trillion to 100 trillion cells. These cells are constantly in a state of flux. About 300 million die every minute, while an equal number are freshly minted. The only cell visible to the naked eye is the ovum. About 10,000 average-sized human cells can fit on the head of a pin. Despite their minuscule size, these biological machines are surprisingly efficient, intelligent and possess remarkable memory.
Can science solve the puzzle of consciousness?
We do not generally think of the cells in our bodies as intelligent or capable of storing data other than those relevant to their function. However, as you will see, our cells process information and engage in purposeful behaviour. They are comparable to, but a lot smarter and more caring than, computer chips that power artificial intelligence. Like AI, cells change and learn from experience, while unlike computer chips they arrive naturally preprogrammed.
Textbooks often depict the cell as a factory, with genes providing instructions to produce proteins that carry out the body's daily functions. Considerable biological research indicates that 'control' and 'information' are distributed throughout the cell rather than concentrated in the nucleus. Cellular organelles do not operate like assembly lines; instead, they engage in intricate interactions with one another. Moreover, the cell's primary role isn't solely focused on 'production' as the common factory metaphor suggests. Rather, a significant portion of its activity is devoted to self-maintenance and supporting the well-being of neighbouring cells. [3].
Cell communication plays a vital role in maintaining tissue balance, co-ordinating specific cellular activities, and responding to environmental signals. During both development and repair, tissues must continually adjust to shifting biological conditions to achieve physiological stability. To do so, cells within these tissues engage in ongoing interactions – either with nearby target cells or, in some cases, with distant cells – without always involving the surrounding local cells.
The art and science of aging well
Cells can talk and help one another by way of the recently discovered tiny tube networks (TNTs). When a stressed or ailing cell releases a chemical distress signal, nearby cells extend hollow tubes through which they pass needed resources such as RNA, proteins or even whole organelles to the sick cell. [4]
Anne-Marie Rodriguez, a researcher at the Mondor Institute of Biomedical Research in Paris, has discovered that TNTs help injured heart cells recover from heart attacks. [5] In addition to TNTs, cells have other options for exchanging molecules, most notably the structures called gap junctions and exosomes.
New research from The Dana-Farber Cancer Institute has revealed that adult tissues retain a memory, inscribed on their DNA, of the embryonic cells from which they arose. [6] This discovery led to an even more fascinating finding that memory is entirely recoverable: 'Beyond the sheer existence of this archive, we were surprised to find that it doesn't remain permanently locked away but can be accessed under certain conditions. The implications of this discovery for how we think about cells' capabilities, and for the future treatment of degenerative and other diseases, are potentially profound,' said Ramesh A. Shivdasani, the senior author of the new study.
In other words, under specific conditions, patient-derived cells could be reverted to a more primitive developmental stage and then guided to grow into mature healthy tissues suitable for replacing damaged or diseased ones. This approach also shows potential in cancer research, especially in understanding how healthy cells 'catch' cancer.
Near-death experiences suggest that our consciousness may not die when our bodies do
Biologists, adapting principles from cybernetics and dynamic systems theory, have argued that the cell is an autopoietic system that continually recreates itself. [7] The word autopoiesis is derived from the Greek words for self and production, and refers to a system that can enact, reproduce, and maintain itself.
To support renewal, human tissues routinely eliminate millions of cells without compromising their overall structure, integrity, or intercellular connections. Researchers at the Institut Pasteur have identified a novel process that helps achieve this: dying cells temporarily shield nearby cells from undergoing cell death, thereby preserving tissue stability.
Using fluorescent markers sensitive to protein activity, the scientists discovered that when a cell dies, it triggers a short-term activation – lasting about an hour – of the EGFR-ERK signalling pathway in surrounding cells. This pathway, already known for its role in promoting cell survival, acts to prevent the simultaneous death of neighbouring cells. 'We were aware of the pathway's significance in epithelial cell survival, but witnessing this protective interaction between cells was unexpected,' said Romain Levayer, head of the Cell Death and Epithelial Homeostasis Unit at the Institut Pasteur and the study's lead author. [8]
Their findings also demonstrate that disrupting this local protective mechanism severely impacts epithelial tissues. Without it, adjacent cells would also die, causing major breakdowns in tissue and organs.
'These results highlight the remarkable self-regulation abilities of biological tissues,' Mr. Levayer explains. 'There's no central control directing when and where cells should die – it all comes down to direct, localized communication between neighbouring cells.'
The magic and mystery of dreams: Nighttime phenomenon's purpose still up for debate
The crucial contribution of the entire single living cell to our health is conventionally overlooked. We humans place extra stress on our cells that they are not really programmed to deal with. Smoking, drinking and sun tanning, if continued for long periods, can cause permanent damage. The same goes for noise, pollution, radiation and the new threat to our health – microplastics. The cells that constitute your skin and the linings of your mouth, lungs and gut are particularly vulnerable. They deserve to be treated with respect.
Unpacking all the above, please note that individual cells are not just building blocks, like bricks in a wall; they have extra competences that enable them to construct larger structures and repair tissues. Cells need not understand, nor have minds, but by possessing information to perform tasks, beginning with the fundamental task of self-preservation, they provide themselves with the energy needed to adjust to their local environments in ways that advance their prospects. As cells form ever larger and more complex networks, their aggregate intelligence and wisdom grows.
One more thing. What I find especially intriguing about cells is the recent revelation by wildlife scientists that all living organisms shed small amounts of genetic material known as environmental DNA, or eDNA. This eDNA is present everywhere, drifting through the air, lingering in water, snow, milk, over grass, on the steps of your house or the chair in your living room. Thanks to recent advances in technology, researchers can now extract increasingly detailed information from ever tinier eDNA samples. In fact, scientists at the Whitney Laboratory for Marine Bioscience and Sea Turtle Hospital at the University of Florida in St. Augustine, have managed to retrieve both medical and ancestral data from trace human DNA fragments found in the environment. [9]
A friend of mine, a very sane person, I assure you, told me of an experience last year while going house hunting in a small Northern Ontario town. After checking out several houses he and his wife were led to a lovely old building. His wife and their real estate agent marched right in. But he froze in terror at the sound of crying and screaming children. He turned around and fled to the other side of the street. When his wife and the agent emerged from the house, they asked him why he did not follow them in. He explained what happened. The agent told them that a hundred years ago this house was an orphanage. Neither my friend nor his wife had any prior knowledge of the history of this house.
So, I am wondering whether this incident and many similar ones as well as seances, occult writings and hundreds of ghost stories, are in some way connected to certain people having a special ability to tune in to persons who had experienced strong negative emotions like fear or suffering by 'reading' their eDNA? Could it be that all of these fragments of DNA that have been piling up for millennia on this planet are responsible for what Carl Jung called 'the collective unconscious?' [10]
References
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Echo Responds to Misinformation with Science: Hydrogen Water Bottles Outperform Tablets in Safety, Efficacy, and Value
Echo Responds to Misinformation with Science: Hydrogen Water Bottles Outperform Tablets in Safety, Efficacy, and Value

National Post

time4 hours ago

  • National Post

Echo Responds to Misinformation with Science: Hydrogen Water Bottles Outperform Tablets in Safety, Efficacy, and Value

Article content SALT LAKE CITY — Echo, the global leader in hydrogen health technology, is responding forcefully to a wave of misinformation being spread by influencers with financial agendas. False claims that the Echo Flask causes heavy metals poisoning or stops working after six months are not only wrong—they're dangerous. Article content 'Hydrogen health is growing fast—and that growth has attracted a swarm of pseudo-scientific influencers using fear, not facts, to push products that pay them more money,' said Josh Carr, CEO of Echo. 'We're done letting those lies go unchallenged.' Article content At the center of the recent smear campaign are false allegations that Echo's hydrogen water bottle stops producing hydrogen after six months and may leach harmful metals. These claims are categorically false, unsupported by any lab data, and contradicted by third-party testing and thousands of happy customers. Article content The Echo Flask is engineered with platinum-coated electrodes, a proprietary proton exchange membrane, and a self-cleaning system—guaranteeing high-concentration hydrogen performance for over 10,000 uses. Echo backs every unit with a 5-year warranty and provides published test results verifying both hydrogen output and water purity. Article content 'These accusations aren't coming from scientists or doctors. They're coming from influencers who make more money when they scare people into buying hydrogen tablets,' Carr said. 'They claim our bottle causes 'heavy metals poisoning,' but produce no lab report, no data—just fear bait.' Article content Echo acknowledges that some low-end hydrogen bottles do degrade quickly—especially those built with cheap electrodes or mass-produced knockoff parts. But the Echo Flask is in a different class: medical-grade materials, clean hydrogen output, and durable construction backed by a decade of engineering. Article content In contrast, hydrogen tablets—often promoted as a better alternative—have major safety, quality, and cost issues. Many contain unregulated magnesium, along with heavy metals like lead, and begin to degrade rapidly the moment you open the package. Article content 'These tablet pushers mislead the public with confusing numbers and manipulated science,' Carr continued. 'They talk about 'high ppm levels' as if that means something useful—but hydrogen dosage is measured in milligrams, not parts per million. A high ppm in a tiny volume can mean a low actual dose. Consumers are literally paying more for less. It's dirty, expensive water with barely any usable hydrogen.' Article content Beyond misleading metrics, tablets are a recurring cost—often over $150/month to match the hydrogen levels the Echo Flask delivers for pennies per day. They're unstable, expensive, and fundamentally misrepresented. Article content 'We've tested these tablets. We've tested our bottles. We publish our data. And we stand behind our technology. That's the difference,' said Carr. 'People deserve truth—not hype.' Article content As the hydrogen wellness category continues to grow, Echo urges consumers to look past influencer theatrics and focus on science, transparency, and value. For third-party test results, hydrogen education, and Echo's full product lineup, visit Article content Article content Article content Article content

UnitedHealth falls short of second quarter expectations and offers weak outlook for 2025
UnitedHealth falls short of second quarter expectations and offers weak outlook for 2025

CTV News

time4 hours ago

  • CTV News

UnitedHealth falls short of second quarter expectations and offers weak outlook for 2025

The logo for UnitedHealth Group appears above a trading post on the floor of the New York Stock Exchange, April 17, 2025. (AP Photo/Richard Drew, file) UnitedHealth delivered disappointing second-quarter earnings and went conservative with its 2025 forecast as soaring medical costs continue to swamp insurers. The health care giant said Tuesday expenses that have jumped beyond what it expected when it set coverage prices will continue to pressure its performance. But the company expects a return to earnings growth in 2026. UnitedHealth now expects adjusted earnings of at least $16 per share in 2025 after withdrawing its previous forecast in May. It had started 2025 with expectations of making up to $30 per share. For the full year, analysts forecast earnings of $20.64 per share, according to the data firm FactSet. UnitedHealth Group Inc. runs one of the nation's largest health insurance and pharmacy benefits management businesses. The Eden Prairie, Minnesota, company also operates a growing Optum business that provides care and technology support. In May, the company withdrew its 2025 forecast due to higher-than-expected medical costs, and CEO Andrew Witty departed the company abruptly. He was replaced by Chairman Stephen Hemsley, who was the UnitedHealth CEO for more than a decade until 2017. That came after the company took the rare step in April of cutting its forecast. That pushed UnitedHealth shares down $130 in its worst single-day performance in over 25 years. Hemsley promised in June that UnitedHealth would establish a 'prudent' 2025 earnings outlook when it detailed second-quarter results. He also said the company had underestimated care activity and cost trends, but improvements were being made. In the second quarter, UnitedHealth reported adjusted earnings of $4.08 per share on $111.6 billion in total revenue. Analysts expected earnings of $4.48 per share on $111.5 billion in revenue, according to FactSet. The company's profit fell 19% to $3.41 billion even as revenue rose 13%. Medical costs, the company's biggest operating expense, jumped 20% to $78.6 billion in the quarter. UnitedHealth is normally the first insurer to report earnings every quarter. But this summer, it followed competitors like Elevance Health Inc. and Centene Corp. that have lowered their annual forecasts and delivered disappointing results. Several insurers say they have been hit by medical costs that are growing faster than expected. Companies have seen a rise in expensive emergency rooms visits and growing prescription drug costs, especially from expensive cancer treatments and gene therapy. They've also seen a rise in behavioral health care, which includes the treatment of mental health conditions and substance use disorders. UnitedHealth shares slid about more than 3% to $272.30 before the opening bell Tuesday. That price topped $630 last November to reach a new all-time high. But the stock has mostly shed value since December, when UnitedHealthcare CEO Brian Thompson was fatally shot in midtown Manhattan on his way to the company's annual investor meeting. Shares are down 44% so far this year. The Dow Jones Industrial Average, of which UnitedHealth is a member, has climbed 5%. Tom Murphy, The Associated Press

Eli Lilly and Loxo Oncology's Promising Study on Pirtobrutinib for CLL/SLL
Eli Lilly and Loxo Oncology's Promising Study on Pirtobrutinib for CLL/SLL

Globe and Mail

time4 hours ago

  • Globe and Mail

Eli Lilly and Loxo Oncology's Promising Study on Pirtobrutinib for CLL/SLL

(LLY)), Loxo Oncology Inc ((LOXO)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Eli Lilly and Company, in collaboration with Loxo Oncology Inc., is conducting a Phase 3 study titled 'A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)'. The study aims to evaluate the efficacy and safety of the experimental drug Pirtobrutinib compared to the standard treatment of Bendamustine plus Rituximab in patients who have not received prior treatment for CLL/SLL. The study tests two interventions: Pirtobrutinib, an oral medication, and a combination of Bendamustine and Rituximab, administered intravenously. Pirtobrutinib is being evaluated for its potential to offer a more effective and safer treatment option. This interventional study is randomized with a parallel assignment model. Participants are divided equally into two groups, with no masking involved. The primary purpose is treatment, allowing crossover for patients with disease progression. The study began on September 23, 2021, with an active but not recruiting status. The last update was submitted on July 22, 2025, indicating ongoing progress. These dates are crucial for tracking the study's development and anticipated results. The outcome of this study could significantly impact Eli Lilly's and Loxo Oncology's stock performance by potentially introducing a new treatment option in the CLL/SLL market. This could influence investor sentiment positively, especially if Pirtobrutinib proves to be a superior treatment. Competitors in the oncology space will be closely monitoring these developments. The study remains active, with further details available on the ClinicalTrials portal.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store